The goal of this program is to improve management of Alzheimer disease (AD), atrial fibrillation (AF), and prostate cancer. After hearing and assimilating this program, the clinician will be better able to:Cite evidence for use of donanemab in early symptomatic AD.Compare rate control vs rhythm control in management of AF.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Family-Medicine
- Start Date: 2024-09-23 05:00:00
- End Date: 2024-09-23 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest